Prosecution Insights
Last updated: April 17, 2026
Application No. 18/213,060

ACCESS PORT CAP SYSTEM AND METHOD OF USE

Non-Final OA §102§103§112
Filed
Jun 22, 2023
Examiner
PATEL, SHEFALI DILIP
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
unknown
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
4y 0m
To Grant
86%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allow Rate
427 granted / 734 resolved
-11.8% vs TC avg
Strong +28% interview lift
Without
With
+27.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
54 currently pending
Career history
788
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
39.4%
-0.6% vs TC avg
§102
25.2%
-14.8% vs TC avg
§112
26.7%
-13.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 734 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification The abstract of the disclosure is objected to because: In line 5, “the circumference” should be changed to “a circumference” A corrected abstract of the disclosure is required and must be presented on a separate sheet, apart from any other text. See MPEP § 608.01(b). Claim Objections Claims 1-3 and 5-7 are objected to because of the following informalities: In regards to claim 1, line 9, “the body” should be changed to “the body of the adhesive member”. In regards to claim 1, lines 9-10, “the circumference” should be changed to “a circumference”. In regards to claim 1, line 10, “an implanted port” should be changed to “the implanted port”. In regards to claim 2, line 1, “the cap’s body” should be changed to “the body of the cap”. In regards to claim 3, line 1, “an angle” should be changed to “the angle”. In regards to claim 5, line 10, “the body” should be changed to “the body of the adhesive member”. In regards to claim 5, lines 10-11, “the circumference” should be changed to “a circumference”. In regards to claim 5, line 11, “an implanted port” should be changed to “the implanted port”. In regards to claim 6, line 1, “the cap’s body” should be changed to “the body of the cap”. In regards to claim 7, line 8, “an implanted port” should be changed to “the implanted port”. In regards to claim 7, line 12, “the body” should be changed to “the body of the adhesive member”. In regards to claim 7, line 13, “the circumference” should be changed to “a circumference”. In regards to claim 7, line 13, “an implanted port” should be changed to “the implanted port”. In regards to claim 7, line 26, “an implanted port” should be changed to “the implanted port”. In regards to claim 7, line 26, “the user’s skin” should be changed to “skin of a user”. In regards to claim 7, line 32, “the user’s skin” should be changed to “the skin of the user”. In regards to claim 7, line 34, “the access cap port system” should be changed to “the access port cap system”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 3 and 5-6 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In regards to claim 3, line 2, the term “approximately 45-degrees” is a relative term which renders the claim indefinite. The term “approximately 45-degrees” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. In regards to claim 5, lines 7-8, the term “approximately 45-degrees” is a relative term which renders the claim indefinite. The term “approximately 45-degrees” is not defined by the claim, the specification does not provide a standard for ascertaining the requisite degree, and one of ordinary skill in the art would not be reasonably apprised of the scope of the invention. Claim 6 is rejected by virtue of being dependent upon claim 5. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-6 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Crain (US 2022/0143381). In regards to claim 1, Crain teaches an access port cap system (Figures 1-7, protector device 2), comprising: a cap (4/6/12), the cap having: a body (6) forming an interior reservoir (12) therein a perimeter lip (4) extending from a base of the body wherein the interior reservoir is configured to provide clearance between the body and a top portion of an implanted port (Figures 2-3, 7) wherein the perimeter lip extends at an angle (labeled in Figure 7 below) for ease of removal an adhesive member (8), the adhesive member having: a body (8) forming an opening (Figure 2) therein, the body configured to surround the circumference of an implanted port (Figures 1-3) a double-sided adhesive tape (8) having a top sticky layer and a bottom sticky layer (paragraph [0023]: The adhesive 8 could be… a double-sided tape disc), the double-sided adhesive tape contained between a top release liner and a bottom release liner (10) (While Crain does teach a bottom release liner (10) attached to the bottom sticky layer (Figure 2), Crain does not explicitly disclose a top release liner attached to the top sticky layer. However, it is noted that claim 1 is drawn to an access port cap system, wherein a top release liner and a bottom release liner are not positively recited structures of the claimed access port cap system. Crain teaches the claimed access port cap system of claim 1 which has the ability to be used with a top release liner and a bottom release liner, as claimed, as the structure of the double-sided adhesive tape (8), as a separate component from the cap (4/6/12) (Figure 2), is capable of being contained between a top release liner and a bottom release liner; thus anticipating said claim limitation) wherein, upon removal of the top release liner, the perimeter lip adheres to the top sticky layer of the double-sided adhesive tape (Figure 1) wherein, upon removal of the bottom release liner, the bottom sticky layer of the double-sided adhesive tape is positioned around the circumference of the implanted port, thereby placing the cap over the implanted port (Figure 3) PNG media_image1.png 262 332 media_image1.png Greyscale In regards to claim 2, Crain teaches wherein the cap's body is dome-shaped (6). In regards to claim 3, Crain teaches wherein the perimeter lip extends at an angle (labeled in Figure 7 above) measured approximately 45-degrees (Figure 7). In regards to claim 4, Crain teaches wherein the double-sided adhesive tape is composed of medical grade double sticky tape (paragraph [0023]: The adhesive 8 could be… a double-sided tape disc). In regards to claim 5, Crain teaches an access port cap system (Figures 1-7, protector device 2), comprising: a cap (4/6/12), the cap having: a body (6) forming an interior reservoir (12) therein a perimeter lip (4) extending from a base of the body wherein the interior reservoir is configured to provide clearance between the body and a top portion of an implanted port (Figures 2-3, 7) wherein the perimeter lip extends at an angle (labeled in Figure 7 above) measured approximately 45-degrees for ease of removal (Figure 7) an adhesive member (8), the adhesive member having: a body (8) forming an opening (Figure 2) therein, the body configured to surround the circumference of an implanted port (Figures 1-3) a double-sided adhesive tape (8) having a top sticky layer and a bottom sticky layer (paragraph [0023]: The adhesive 8 could be… a double-sided tape disc), the double-sided adhesive tape contained between a top release liner and a bottom release liner (10) (While Crain does teach a bottom release liner (10) attached to the bottom sticky layer (Figure 2), Crain does not explicitly disclose a top release liner attached to the top sticky layer. However, it is noted that claim 5 is drawn to an access port cap system, wherein a top release liner and a bottom release liner are not positively recited structures of the claimed access port cap system. Crain teaches the claimed access port cap system of claim 5 which has the ability to be used with a top release liner and a bottom release liner, as claimed, as the structure of the double-sided adhesive tape (8), as a separate component from the cap (4/6/12) (Figure 2), is capable of being contained between a top release liner and a bottom release liner; thus anticipating said claim limitation) wherein the double-sided adhesive tape is composed of medical grade double sticky tape (paragraph [0023]: The adhesive 8 could be… a double-sided tape disc) wherein, upon removal of the top release liner, the perimeter lip adheres to the top sticky layer of the double-sided adhesive tape (Figure 1) wherein, upon removal of the bottom release liner, the bottom sticky layer of the double-sided adhesive tape is positioned around the circumference of the implanted port, thereby placing the cap over the implanted port (Figure 3) In regards to claim 6, Crain teaches wherein the cap's body is dome-shaped (6). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Crain, and further in view of McGee (US 2008/0047664) and Shultz (US 12,109,318). Note: the cited subject matter of Shultz (US 12,109,318) is applicable as supported in earlier-filed US 17/694,312, filed on March 14, 2022, and US 63/209,450, filed on June 11, 2021, before the effective filing date of Applicant’s claimed invention of July 20, 2022. In regards to claim 7, Crain teaches a method for preventing pain when an implanted port is accessed (paragraph [0002]: The present invention relates generally to a port protector and cover system and method for use thereof, and more specifically to a cover and protector for port catheter devices installed in patients which serve to prevent creams and lidocaine from leaking away from the porta catheter site and to prevent pain and discomfort associated with bumping or snagging objects and clothing), the method comprising: providing an access port cap system (Figures 1-7, protector device 2), the access port cap system comprising: a cap (4/6/12), the cap having: a body (6) forming an interior reservoir (12) therein a perimeter lip (4) extending from a base of the body wherein the interior reservoir is configured to provide clearance between the body and a top portion of an implanted port (Figures 2-3, 7) wherein the perimeter lip extends at an angle (labeled in Figure 7 above) for ease of removal an adhesive member (8), the adhesive member having: a body (8) forming an opening (Figure 2) therein, the body configured to surround the circumference of an implanted port (Figures 1-3) a double-sided adhesive tape (8) having a top sticky layer and a bottom sticky layer (paragraph [0023]: The adhesive 8 could be… a double-sided tape disc) wherein, the perimeter lip adheres to the top sticky layer of the double-sided adhesive tape (Figure 1) wherein, upon removal of the bottom release liner (10), the bottom sticky layer of the double-sided adhesive tape is positioned around the circumference of the implanted port, thereby placing the cap over the implanted port (Figures 2-3) adhering the perimeter lip to the exposed top sticky layer (Figure 2 to Figure 1) topically applying a relatively thick layer of a numbing agent over a raised portion of an implanted port within the user's skin (Abstract: lidocaine applied to the site of the porta catheter) removing the bottom release liner to expose the bottom sticky layer of the double- sided adhesive tape (Figure 2) positioning the exposed bottom sticky layer around the circumference of the implanted port, thereby placing the cap over the implanted port, and by extension, the numbing agent (Figure 3)(paragraph [0022]: A dome 6 rises up away from the flat rim 4, forming an interior space 12 for protecting the access port 16 and which may contain… lidocaine) While Crain does teach a bottom release liner (10) attached to the bottom sticky layer (Figure 2), Crain does not explicitly disclose a top release liner attached to the top sticky layer, resulting in the double-sided adhesive tape contained between a top release liner and a bottom release liner. And thus Crain also does not teach removal of the top release liner and removing the top release liner to expose the top sticky layer of the double-sided adhesive tape. McGee teaches a method comprising: an adhesive member (1) having: a double-sided adhesive tape (1) having a top sticky layer (2) and a bottom sticky layer (3), the double-sided adhesive tape contained between a top release liner (5) and a bottom release liner (paragraph [0028]: protective release liner), removal of the top release liner (paragraph [0030]: liner 5 is removed), and removing the top release liner to expose the top sticky layer of the double-sided adhesive tape (paragraph [0030]: liner 5 is removed to expose the adhesive coating of top side 2). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to modify the method, of Crain, with a top release liner, resulting in the double-sided adhesive tape contained between a top release liner and a bottom release liner, removal of the top release liner, and removing the top release liner to expose the top sticky layer of the double-sided adhesive tape, as taught by McGee, as such will protect the top sticky layer, until a second surface is required to be bonded, and this is accomplished by first removing the top release liner from the top sticky layer of the tape and then bonding the top sticky layer of the tape to the second surface (paragraph [0003]). Further, while Crain teaches the numbing agent (Abstract: lidocaine), Crain is silent about allowing the user's skin to absorb the numbing agent for a predetermined amount of time. And Crain is silent about removing the access cap port system to allow the implanted port to be accessed. Shultz teaches a method for preventing pain when an implanted port is accessed, the method comprising: allowing a user's skin to absorb a numbing agent for a predetermined amount of time (column 22, lines 54-60: Generally, the patient leaves the device over the port site for a sufficient period of time to numb the port site, typically about 10 minutes to an hour... During this time, the medication in the compartment is in contact with the port site), and removing an access cap port system to allow the implanted port to be accessed (column 22, lines 61-62: Immediately prior to accessing the implanted port, the device is removed from the patient's skin). It would have been obvious to a person having ordinary skill in the art before the effective filing date of the claimed invention to modify the modified method, of Crain and McGee, with allowing the user's skin to absorb the numbing agent for a predetermined amount of time, and removing the access cap port system to allow the implanted port to be accessed, as taught by Shultz, as such will allow for managing chronic illness, such as cancer and autoimmune and neurological disorders by the implanted port allowing medical professionals easy, reliable access to administer medicine, vitamins, and/or other necessary liquids to a patient directly into the veins and allowing medical professionals the ability to withdraw blood from a patient for labs easier and generally more comfortable for the patient than multiple needle sticks (column 1, lines 21-35). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHEFALI D PATEL whose telephone number is (571)270-3645. The examiner can normally be reached Monday-Friday 8:30am-4:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin C Sirmons can be reached at (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHEFALI D PATEL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Jun 22, 2023
Application Filed
Dec 30, 2025
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599708
PERITONEAL DIALYSIS CASSETTE
2y 5m to grant Granted Apr 14, 2026
Patent 12589219
STEERABLE SHEATH WITH VARIABLE CURVE SPAN
2y 5m to grant Granted Mar 31, 2026
Patent 12582775
PULSATILE OR RESONATING FLUSH SYRINGE
2y 5m to grant Granted Mar 24, 2026
Patent 12564678
SYSTEMS AND METHODS FOR OPTIMIZING MEDICAMENT DOSING
2y 5m to grant Granted Mar 03, 2026
Patent 12551605
FLUID LINE AUTOCONNECT APPARATUS AND METHODS FOR MEDICAL TREATMENT SYSTEM
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
86%
With Interview (+27.7%)
4y 0m
Median Time to Grant
Low
PTA Risk
Based on 734 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month